Assess whether regulatory approval is a timing risk or a deal risk (8662a5)

SITUATION The working file is earnout metric definitions that invite dispute after a founder who will not sign a non-compete. Integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on has to name Regulatory approval is a timing risk or A deal risk for this M&A Due Diligence People and Contracts file.

DECISION Integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on must choose Regulatory approval is a timing risk / A deal risk using earnout metric definitions that invite dispute after a founder who will not sign a non-compete.

HYPOTHESES TO TEST 1. The population in earnout metric definitions that invite dispute is the one a founder who will not sign a non-compete named, so Regulatory approval is a timing risk follows for this People and Contracts file. 2. The population in earnout metric definitions that invite dispute is adjacent only to a founder who will not sign a non-compete; A deal risk is the honest M&A Due Diligence call. 3. A PE platform evaluating a founder-led SaaS add-on already contained a founder who will not sign a non-compete before earnout metric definitions that invite dispute arrived; no new People and Contracts path. 4. Provenance on earnout metric definitions that invite dispute after a founder who will not sign a non-compete is broken; do not pick Regulatory approval is a timing risk or A deal risk yet.

ANALYSIS REQUIRED 1. Name the document integration-risk PMO still needs before signing. 2. Test whether a founder who will not sign a non-compete is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in earnout metric definitions that invite dispute. 4. For this M&A Due Diligence People and Contracts file, read earnout metric definitions that invite dispute against a founder who will not sign a non-compete and write the one fact that would move regulatory approval is a for integration-risk PMO.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / People and Contracts packet (earnout metric definitions that invite dispute after a founder who will not sign a non-compete). If earnout metric definitions that invite dispute cannot force a M&A Due Diligence label under People and Contracts, stop. If earnout metric definitions that invite dispute after a founder who will not sign a non-compete cannot support Regulatory approval is a timing risk versus A deal risk on this M&A Due Diligence People and Contracts close, integration-risk PMO must do not proceed, reprice, or walk on a quality-of-earnings fact the packet does not carry.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in earnout metric definitions that invite dispute, then the action for integration-risk PMO - Hypothesis scorecard against earnout metric definitions that invite dispute: supported / rejected / untestable - Owner and next date for integration-risk PMO in a PE platform evaluating a founder-led SaaS add-on - What changes regulatory approval is a if a founder who will not sign a non-compete is later withdrawn